Cargando…

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening: Intervention Eligibility, Strategy Choice, and Optimality

INTRODUCTION: There is increasing interest in risk-stratified approaches to cancer screening in cost-effectiveness analysis (CEA). Current CEA practice regarding risk stratification is heterogeneous and guidance on the best approach is lacking. This article suggests how stratification in CEA can be...

Descripción completa

Detalles Bibliográficos
Autor principal:	O’Mahony, James F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005837/ https://www.ncbi.nlm.nih.gov/pubmed/34634972 http://dx.doi.org/10.1177/0272989X211050918

Ejemplares similares

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification
por: Fabbro, Matthew, et al.
Publicado: (2022)

A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?
por: Pokharel, Rajani, et al.
Publicado: (2023)

Interpreting cost-effectiveness ratios in a cost-effectiveness analysis of risk-tailored prostate screening: A critique of Callender et al.
por: O'Mahony, James F.
Publicado: (2020)

Cost-effectiveness of population-based screening for colorectal cancer
por: O'Mahony, J F
Publicado: (2013)

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs
por: O’Mahony, James F.
Publicado: (2021)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
por: Lin, Yi-Shu, et al.
Publicado: (2023)

Public Preferences for Determining Eligibility for Screening in Risk-Stratified Cancer Screening Programs: A Discrete Choice Experiment
por: Dennison, Rebecca A., et al.
Publicado: (2023)

A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening
por: Dennison, Rebecca A., et al.
Publicado: (2022)

Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population‐based survey
por: Usher‐Smith, Juliet A., et al.
Publicado: (2020)

Using Risk Stratification to Optimize Mammography Screening in Chinese Women
por: Leung, Kathy, et al.
Publicado: (2021)

Optimal risk stratification and therapeutic strategy for acute myocardial infarction
por: Imamura, Teruhiko
Publicado: (2021)

Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer
por: Lubbock, Alexander L. R., et al.
Publicado: (2017)

Outcome choice and definition in systematic reviews leads to few eligible studies included in meta-analyses: a case study
por: Saldanha, Ian J., et al.
Publicado: (2020)

EU Regulatory Risk Management of Marine Biotoxins in the Marine Bivalve Mollusc Food-Chain
por: O’Mahony, Micheál
Publicado: (2018)

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
por: Vilaprinyo, Ester, et al.
Publicado: (2014)

Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
por: Anderson, John E., et al.
Publicado: (2020)

Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management
por: Cesena, Fernando Henpin Yue, et al.
Publicado: (2017)

A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil
por: Miranda-Filho, Adalberto, et al.
Publicado: (2021)

Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data
por: Preen, David B., et al.
Publicado: (2017)

Cervical screening during the COVID-19 pandemic: optimising recovery strategies
por: Castanon, Alejandra, et al.
Publicado: (2021)

Carrier Screening is a Deficient Strategy for Determining Sperm Donor Eligibility and Reducing Risk of Disease in Recipient Children
por: Silver, Ari J., et al.
Publicado: (2016)

Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials
por: Kim, Jae Hyun, et al.
Publicado: (2020)

Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population
por: Schiffelbein, Jenna E., et al.
Publicado: (2020)

Economic Cost of Functional Neurologic Disorders: A Systematic Review
por: O'Mahony, Brian, et al.
Publicado: (2023)

An optimization framework to guide the choice of thresholds for risk-based cancer screening
por: Brentnall, Adam R., et al.
Publicado: (2023)

The Dilemma of Choice for Duchenne Patients Eligible for Exon 51 Skipping The European Experience
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2023)

The efficacy of interventions in reducing belief in conspiracy theories: A systematic review
por: O’Mahony, Cian, et al.
Publicado: (2023)

Data on Medicare eligibility and cancer screening utilization
por: Meyer, Christian P., et al.
Publicado: (2016)

Implementation strategies to support fall prevention interventions in long-term care facilities for older persons: a systematic review
por: Albasha, Neah, et al.
Publicado: (2023)

Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization
por: Salari, Paola, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA
por: O’Day, Ken, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2021)

Reply to the Letter to the Editor Entitled “Optimal risk stratification and therapeutic strategy for acute myocardial infarction”
por: Wang, Sheng‐ji, et al.
Publicado: (2021)

Bifidobacterium Infantis 35624 Protects Against Salmonella-Induced Reductions in Digestive Enzyme Activity in Mice by Attenuation of the Host Inflammatory Response
por: Symonds, Erin L, et al.
Publicado: (2012)

Diabetes screening intervals based on risk stratification
por: Ohde, Sachiko, et al.
Publicado: (2016)

Eligibility for cardiovascular risk screening among different ethnic groups: The HELIUS study
por: Perini, Wilco, et al.
Publicado: (2019)

Eligibility Screening for an Early Upper Limb Stroke Rehabilitation Study
por: Held, Jeremia P. O., et al.
Publicado: (2019)

Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting
por: Congly, Stephen E., et al.
Publicado: (2021)

Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review
por: Ekwunife, Obinna I., et al.
Publicado: (2015)

The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis
por: Thomas, Chloe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rlmqpcrvsvq4lsep8e7ghc4p5n